Clinical trial
Treatment for Completers of the Study B7A-MC-MBCM
NCT00266695
Study timeline
Study start (unknown)2006-01-01Date precision: month
Registry last updated2016-10-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Retinopathyunresolved
Interventions
RuboxistaurinDRUG
Sponsors & collaborators
Chromaderm, Inc.lead sponsor
Mapped research locations
BostonMassachusetts, United States1DallasTexas, United States1BaltimoreMaryland, United States1PittsburghPennsylvania, United States1CincinnatiOhio, United States1TampaFlorida, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1Salt Lake CityUtah, United States1CharlotteNorth Carolina, United States1SacramentoCalifornia, United States1MadisonWisconsin, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00266695 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.